rss
05-01-2014, 01:00 AM
Sorin Mitroflow Aortic Heart Valve With New Phospholipid Reduction Treatment Approved by FDA
http://cdn.medgadget.com/wp-content/uploads/2014/04/gbj23fdidkdk.jpg
Sorin received FDA approval to bring to the U.S. market its Mitroflow aortic heart valve with*Phospholipid Reduction Treatment (PRT). Already approved in Europe three years ago (http://www.medgadget.com/2011/08/mitroflow-aortic-pericardial-heart-valve-with-phospholipid-reduction-treatment-gets-eu-ok.html), the material treatment*is designed to*to help prevent calcification on the*surface by reducing the phospholipid content on the valve.
The Mitroflow valve itself has been around for three decades with a proven track record, and the new phospholipid treatment will hopefully make it last in situ considerably longer than previous models.
Flashback:*Mitroflow Aortic Pericardial Heart Valve with Phospholipid Reduction Treatment Gets EU OK… (http://www.medgadget.com/2011/08/mitroflow-aortic-pericardial-heart-valve-with-phospholipid-reduction-treatment-gets-eu-ok.html)
Product page: Mitroflow with PRT… (http://www.sorin.com/product/mitroflowreg-aortic-pericardial-heart-valve)
Press release: Sorin Group Receives FDA Approval For The Mitroflow(TM) Aortic Heart Valve With New Phospholipid Reduction Treatment… (http://www.sorin.com/**de/3096)
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=f5yZ1tcPI64:FX4tba94xx0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=f5yZ1tcPI64:FX4tba94xx0:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=f5yZ1tcPI64:FX4tba94xx0:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=f5yZ1tcPI64:FX4tba94xx0:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/f5yZ1tcPI64
http://cdn.medgadget.com/wp-content/uploads/2014/04/gbj23fdidkdk.jpg
Sorin received FDA approval to bring to the U.S. market its Mitroflow aortic heart valve with*Phospholipid Reduction Treatment (PRT). Already approved in Europe three years ago (http://www.medgadget.com/2011/08/mitroflow-aortic-pericardial-heart-valve-with-phospholipid-reduction-treatment-gets-eu-ok.html), the material treatment*is designed to*to help prevent calcification on the*surface by reducing the phospholipid content on the valve.
The Mitroflow valve itself has been around for three decades with a proven track record, and the new phospholipid treatment will hopefully make it last in situ considerably longer than previous models.
Flashback:*Mitroflow Aortic Pericardial Heart Valve with Phospholipid Reduction Treatment Gets EU OK… (http://www.medgadget.com/2011/08/mitroflow-aortic-pericardial-heart-valve-with-phospholipid-reduction-treatment-gets-eu-ok.html)
Product page: Mitroflow with PRT… (http://www.sorin.com/product/mitroflowreg-aortic-pericardial-heart-valve)
Press release: Sorin Group Receives FDA Approval For The Mitroflow(TM) Aortic Heart Valve With New Phospholipid Reduction Treatment… (http://www.sorin.com/**de/3096)
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=f5yZ1tcPI64:FX4tba94xx0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=f5yZ1tcPI64:FX4tba94xx0:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=f5yZ1tcPI64:FX4tba94xx0:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=f5yZ1tcPI64:FX4tba94xx0:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/f5yZ1tcPI64